Physiological Saline Market
According to our new research study on "Physiological Saline Market Forecast to 2030 – Global Analysis – by Type, Packaging Type, Application, Route of Administration, and End User," the physiological saline market size was valued at US$ 5,522.17 million in 2022 and is projected to reach US$ 9,057.04 million by 2030. The market is estimated to register a CAGR of 6.4% during 2022–2030.
Packaging Type-Based Insights
The physiological saline market, by packaging type, is segmented into flexible bags, plastic bottles, and glass bottles. The plastic bottles segment held the largest market share in 2022. The flexible bags segment is anticipated to register the highest CAGR during 2022–2030. Sodium chloride (NaCl) USP solutions for injections are sterile and nonpyrogenic. They are parenteral solutions that contain various concentrations of NaCl in water for injection (WFI) intended for intravenous (IV) administration. Further, the flexible container is fabricated from a specially formulated polyvinyl chloride. However, solutions stored in plastic containers might trigger the leaching of certain chemical components from the plastic in tiny amounts. Nonetheless, the safety of plastic container materials can be tested effectively through biological evaluation methods. The plastic bottles segment is expected to account for the smallest share of the physiological saline market during the forecast period.
Physiological Saline Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Normal Saline, Hypertonic Saline, Hypotonic Saline, and Balanced Saline), Packaging Type (Flexible Bags, Plastic Bottles, and Glass Bottles), Application (Intravenous, Ophthalmology, Wound Care, Endoscopy, Skin Abrasion, and Others), Route of Administration (Intravenous and Topical), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Physiological Saline Market Size Report | Share Forecasts to 2030
Download Free Sample
Fresenius Kabi AG, Merck KGaA, AdipoGen Life Sciences Inc, Enzo Life Sciences Inc, ICU Medical Inc, Grifols SA, Geno Technology Inc, B Braun Medical Inc, Pfizer Inc, and Ward's Science are among the leading companies operating in the physiological saline market.
Market Opportunities
Rapid Sample Transportation Using Low-Cost Saline Solutions
A less expensive and readily available saline solution can be used for the safe transportation of testing samples, enabling more effective, long-distance transportation of samples to diagnostic labs. A readily available saline solution such as "phosphate-buffered saline," which is a simple salt solution commonly available in hospitals and clinical laboratories, was in use as a transport medium for coronavirus-contaminated specimens; the saline could keep the samples stable for up to 18 hours. During the COVID-19 pandemic, a shortage of viral transport media posed a major challenge in the transportation of specimens obtained from COVID-19 patients to diagnostics and testing labs, which resulted in an upsurge in the demand for sterile saline solutions. As a result, researchers recommended using inexpensive and commonly available salt solutions such as phosphate-buffered saline solutions for transportation. Therefore, the rising awareness of less expensive and readily available saline solutions, and their use in the transportation of medical specimens are likely to provide opportunities to the physiological saline market during the forecast period.
Innovative Product Launches
Innovative product launches are likely to accelerate the demand for physiological saline worldwide in the coming years. The Food and Drug Administration (FDA) has approved Grifols physiological saline solution in 500-millimeter polypropylene bags for hospitals in the US. The company took this measure to help medical professionals ensure the well-being of blood donors by replacing fluids and restoring circulatory volume. In April 2023, 3M Health Care announced the introduction of a new FDA-approved SoluPrep sterile antiseptic solution. The newly approved product provides fast-acting, broad-spectrum antimicrobial activity and persistence in healthy human volunteers. 3M had plans to begin the limited commercial release of 3M SoluPrep S Steril Antiseptic Solution in April 2023 and the full commercial launch in 2024. Therefore, with innovative product launches by manufacturers in the medical and biotechnology industries would accelerate demand for physiological saline during the forecast period.
In terms of geography, the physiological saline market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com